Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Inherited Retinal Disease Market Growth From $13.6 Billion In 2026 To $18.61 Billion By 2030 At A CAGR Of 8.2%
The inherited retinal disease market size has grown strongly in recent years. It will grow from $12.54 billion in 2025 to $13.6 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to identification of disease-causing retinal genes, advancements in retinal imaging technologies, increased awareness of inherited eye disorders, growth of specialized ophthalmology clinics, public and private funding for rare disease research.
The inherited retinal disease market size is expected to see strong growth in the next few years. It will grow to $18.62 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to advancements in gene therapy platforms, rising approvals of novel retinal therapies, increasing availability of genetic screening programs, expansion of precision medicine initiatives, growing investment in rare ophthalmic disease pipelines. Major trends in the forecast period include increasing adoption of genetic testing for early diagnosis, growing focus on gene and cell-based therapies, expansion of personalized treatment approaches, rising clinical trials for rare retinal disorders, improved patient access to advanced retinal imaging.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20850&type=smp
Inherited Retinal Disease Market Expansion Drivers: What Is Shaping Future Growth?
The increasing prevalence of macular degeneration is expected to propel the growth of the inherited retinal disease market going forward. Macular degeneration is an age-related eye condition that damages the macula, leading to central vision loss and difficulty in activities such as reading or recognizing faces. The increasing prevalence of macular degeneration is driven by aging populations, higher life expectancy, and lifestyle factors such as smoking and poor nutrition, which elevate risk. Inherited retinal disease treatment helps macular degeneration patients by targeting the underlying genetic causes of retinal degeneration, providing therapies that slow disease progression, restore lost vision, or even prevent further damage to the retina, ultimately improving visual outcomes and quality of life for individuals affected by age-related or inherited forms of macular degeneration. For instance, in February 2024, according to the Canadian Ophthalmological Society, a Canada-based nonprofit organization, reported that 2.5 million people in Canada aged over 55 lose their vision due to age-related macular degeneration (AMD). Therefore, the increasing prevalence of macular degeneration is driving the growth of the inherited retinal disease market.
Inherited Retinal Disease Market Segment Analysis Highlighting Growth Areas
The inherited retinal disease market covered in this report is segmented –
1) By Type: Diagnosis, Therapy
2) By Disease Type: Retinitis Pigmentosa, Choroideremia, Stargardt Disease, Cone-rod Dystrophy, Leber Congenital Amaurosis, Other Diseases
3) By Distribution Channel: Retail Sales, Direct Tender
4) By End User: Hospitals, Speciality Clinics, Ambulatory Surgical Centres, Home Healthcare, Other End Users
Subsegments:
1) By Diagnosis: Genetic Testing, Retinal Imaging, Electrophysiological Testing (Electroretinography), Visual Field Testing, Fundus Autofluorescence Imaging
2) By Therapy: Gene Therapy, Stem Cell Therapy, Retinal Prosthesis (Artificial Retina), Pharmacological Therapy, Photoreceptor Rescue Therapy
Inherited Retinal Disease Market Strategic Trends: What Is Defining The Next Phase Of Growth?
Major companies operating in the inherited retinal diseases market focus on developing innovative therapies, such as mutation-agnostic gene therapy, to provide inclusive treatment options and address a wider range of genetic variations associated with these conditions. Mutation-agnostic gene therapy is a treatment approach targeting broader genetic mechanisms or pathways, rather than specific mutations, making it applicable to diverse genetic disorders. For instance, in March 2024, Nanoscope Therapeutics Inc, a US-based biotechnology company, announced positive results of a clinical trial of its lead program, MCO-010, which demonstrates vision improvements for patients with permanent and severe vision loss from advanced retinitis pigmentosa. MCO-010 achieved its primary and key secondary endpoints with statistical significance and no serious adverse events.
Inherited Retinal Disease Market Leading Companies: Who Holds Significant Market Presence?
Major companies operating in the inherited retinal disease market are Johnson & Johnson, Novartis AG, Astellas Pharma Inc., Biogen Inc., Ionis Pharmaceuticals Inc., Invitae Corporation, Spark Therapeutics, Aldeyra Therapeutics, Regenxbio Inc., IVERIC bio, MeiraGTx Limited, Ocugen Inc., Coave Therapeutics, Bionic Vision Technologies, GenSight Biologics SA, LKC Technologies Inc., Sparing Vision, ProQR Therapeutics NV, Endogena Therapeutics
Access The Complete Inherited Retinal Disease Market Report:
https://www.thebusinessresearchcompany.com/report/inherited-retinal-disease-global-market-report
Inherited Retinal Disease Market Leading Geography: Which Region Generates The Most Revenue?
North Americawas the largest region in the inherited retinal disease market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the inherited retinal disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
